Esophageal Manometry and Impedance Study in Obese Patients Before and During Anesthesia

Sponsor
Örebro University, Sweden (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01703897
Collaborator
(none)
0
1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effects of anesthesia on the esophageal body in obese patients before and during anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Device: Manometry and Impedance analysis

Detailed Description

Obesity is an increasing heath problem in western countries and is associated with increased risks during anesthesia.

Using high-resolution solid-state manometry the investigators aim to study esophageal pressures and measure the incidence of regurgitation of gastric contents during anesthesia induction in obese patients. The investigators aim to include 16 obese patients, with BMI > 35, undergoing laparoscopic gastric by-pass.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Esophageal Pressures and Reflux in Obese Patients Before and During Anesthesia Using High-resolution Solid-state Manometry
Study Start Date :
Oct 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Obese patients

Device: Manometry and Impedance analysis

Outcome Measures

Primary Outcome Measures

  1. Esophageal pressures after laparoscopic gastric by pass [2 years after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female patients

  • aged 18-60 years

  • BMI>35

  • ASA classification I-III

Exclusion Criteria:
  • Use of drugs that interfere with esophageal motility

  • Gastro-esophageal reflux disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology and Intensive care, University Hospital of Örebro Örebro Sweden 70162

Sponsors and Collaborators

  • Örebro University, Sweden

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alex de Leon, MD, PhD, Örebro University, Sweden
ClinicalTrials.gov Identifier:
NCT01703897
Other Study ID Numbers:
  • Linde-Imped
First Posted:
Oct 11, 2012
Last Update Posted:
Nov 5, 2014
Last Verified:
Nov 1, 2014
Keywords provided by Alex de Leon, MD, PhD, Örebro University, Sweden

Study Results

No Results Posted as of Nov 5, 2014